VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+15.01%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$115M
AUM Growth
+$115M
(+45%)
Cap. Flow
+$32.6M
Cap. Flow
% of AUM
28.25%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
267
New
23
Increased
109
Reduced
60
Closed
21
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.4M |
| 2 |
Geron
GERN
|
$870K |
| 3 |
Iovance Biotherapeutics
IOVA
|
$856K |
| 4 |
iShares MSCI India ETF
INDA
|
$838K |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$759K |
Top Sells
| 1 |
ProShares Ultra Utilities
UPW
|
$1.12M |
| 2 |
Vanguard Energy ETF
VDE
|
$721K |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$612K |
| 4 |
Fidelity MSCI Information Technology Index ETF
FTEC
|
$421K |
| 5 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$359K |
Sector Composition
| 1 | Healthcare | 78.8% |
| 2 | Financials | 0.81% |
| 3 | Technology | 0.52% |
| 4 | Consumer Discretionary | 0.44% |
| 5 | Communication Services | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Esperion Therapeutics
ESPR
$490M
| $936K | 0.81% |
12,943
+6,886
| +114% | +$498K |
|
52
Travere Therapeutics
TVTX
$1.75B
| $935K | 0.81% |
41,803
-2,494
| -6% | -$55.8K |
|
|
GBT
53
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $934K | 0.81% |
19,331
+9,941
| +106% | +$480K |
|
|
LJPC
54
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $928K | 0.81% |
31,173
+16,779
| +117% | +$500K |
|
|
BPMC
55
DELISTED
Blueprint Medicines
BPMC
| $920K | 0.8% |
10,029
+5,418
| +118% | +$497K |
|
|
SGEN
56
DELISTED
Seagen Inc. Common Stock
SGEN
| $915K | 0.79% |
17,480
-1,023
| -6% | -$53.5K |
|
57
Ironwood Pharmaceuticals
IRWD
$201M
| $911K | 0.79% |
70,463
-4,162
| -6% | -$53.8K |
|
|
ICPT
58
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $903K | 0.78% |
14,681
-861
| -6% | -$53K |
|
59
Halozyme
HALO
$8.75B
| $898K | 0.78% |
45,820
-2,581
| -5% | -$50.6K |
|
60
Amicus Therapeutics
FOLD
$2.42B
| $885K | 0.77% |
58,836
+31,595
| +116% | +$475K |
|
61
Sangamo Therapeutics
SGMO
$161M
| $883K | 0.77% |
46,449
+24,858
| +115% | +$473K |
|
|
IMMU
62
DELISTED
Immunomedics Inc
IMMU
| $882K | 0.77% |
60,362
+32,166
| +114% | +$470K |
|
63
Ultragenyx Pharmaceutical
RARE
$3.04B
| $866K | 0.75% |
16,983
+9,090
| +115% | +$464K |
|
|
KDNY
64
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $859K | 0.75% |
18,480
+9,933
| +116% | +$462K |
|
|
PVLA
65
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
| $857K | 0.74% |
1,571
+856
| +120% | +$467K |
|
66
FibroGen
FGEN
$48.4M
| $844K | 0.73% |
730
+388
| +113% | +$449K |
|
67
BioMarin Pharmaceuticals
BMRN
$11.3B
| $836K | 0.73% |
10,311
-599
| -5% | -$48.6K |
|
68
Inovio Pharmaceuticals
INO
$144M
| $823K | 0.71% |
14,565
+7,827
| +116% | +$442K |
|
|
XLRN
69
DELISTED
Acceleron Pharma Inc.
XLRN
| $814K | 0.71% |
20,821
+11,073
| +114% | +$433K |
|
|
KERX
70
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $814K | 0.71% |
199,089
-11,577
| -5% | -$47.3K |
|
71
Regeneron Pharmaceuticals
REGN
$59.8B
| $810K | 0.7% |
2,352
-174
| -7% | -$59.9K |
|
72
Theravance Biopharma
TBPH
$692M
| $800K | 0.69% |
32,989
-1,940
| -6% | -$47K |
|
73
Incyte
INCY
$17B
| $795K | 0.69% |
9,537
-668
| -7% | -$55.7K |
|
74
Regenxbio
RGNX
$498M
| $793K | 0.69% |
26,560
+14,309
| +117% | +$427K |
|
|
STML
75
DELISTED
Stemline Therapeutics, Inc.
STML
| $791K | 0.69% |
51,678
+27,720
| +116% | +$424K |
|